<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">West J Emerg Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">West J Emerg Med</journal-id>
      <journal-id journal-id-type="publisher-id">WestJEM</journal-id>
      <journal-title-group>
        <journal-title>Western Journal of Emergency Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1936-900X</issn>
      <issn pub-type="epub">1936-9018</issn>
      <publisher>
        <publisher-name>Department of Emergency Medicine, University of California, Irvine School of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25671031</article-id>
      <article-id pub-id-type="pmc">4307706</article-id>
      <article-id pub-id-type="doi">10.5811/westjem.2014.10.24292</article-id>
      <article-id pub-id-type="publisher-id">wjem-16-163</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Diagnostic Acumen</subject>
          <subj-group subj-group-type="heading">
            <subject>Images in Emergency Medicine</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tense Bullae and Urticaria in a Woman in Her Sixties</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wurlitzer</surname>
            <given-names>Katherine C.</given-names>
          </name>
          <degrees>BS</degrees>
          <xref ref-type="aff" rid="af1-wjem-16-163">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Canders</surname>
            <given-names>Caleb P.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="af2-wjem-16-163">&#x2020;</xref>
          <xref ref-type="corresp" rid="c1-wjem-16-163"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campen</surname>
            <given-names>Angelique S.</given-names>
          </name>
          <degrees>MD, MBA</degrees>
          <xref ref-type="aff" rid="af2-wjem-16-163">&#x2020;</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-wjem-16-163"><label>*</label>Sydney Kimmel Medical College, Philadelphia, Pennsylvania</aff>
      <aff id="af2-wjem-16-163"><label>&#x2020;</label>UCLA Medical Center, Department of Emergency Medicine, Los Angeles, California</aff>
      <author-notes>
        <corresp id="c1-wjem-16-163">Address for Correspondence: Caleb P. Canders, MD, Department of Emergency Medicine, David Geffen School of Medicine at UCLA, 924 Westwood Blvd., Suite 300 | Box 951777 Los Angeles, CA 90095-1777. Email: <email>ccanders@mednet.ucla.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>02</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <volume>16</volume>
      <issue>1</issue>
      <fpage>163</fpage>
      <lpage>164</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 the authors.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Non-Commercial Attribution License, which permits its use in any digital medium, provided the original work is properly cited and not altered. For details, please refer to <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>. Authors grant Western Journal of Emergency Medicine a nonexclusive license to publish the manuscript.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE</title>
      <p>A 68-year-old woman presented with a pruritic, blistering rash. Three months prior, she had developed itchy lesions on her hands and feet, spreading to her chest and abdomen. For the past week, she had developed painful, tense blisters. The patient had seen her primary care doctor at symptom onset and failed to improve with topical clobetasol proprionate and hydroxyzine. She took amlodipine for blood pressure and denied any new medications or exposures. Physical examination was notable for bullae with mucosal-sparing, urticaria, negative Nikolsky&#x2019;s sign, and the absence of scarring over ruptured bullae (<xref ref-type="fig" rid="f1-wjem-16-163">Figures 1</xref>&#x2013;<xref ref-type="fig" rid="f3-wjem-16-163">3</xref>). Her complete blood cell count showed an increased number of eosinophils.</p>
    </sec>
    <sec>
      <title>DIAGNOSIS</title>
      <p>Bullous pemphigoid, first identified in 1953, is the most common autoimmune blistering disorder.<xref rid="b1-wjem-16-163" ref-type="bibr">1</xref> It has an annual incidence of 6&#x2013;7 new cases per one million persons, occurs equally in men and women, and typically develops in the seventh or eighth decade of life.<xref rid="b1-wjem-16-163" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref> The disease is characterized by IgG auto-antibodies against the basement membrane hemidesmosome, located at the dermal-epidermal junction.<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref>&#x2013;<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref> Circulating and tissue-bound auto-antibodies bind to target antigens, leading to complement activation, mast cell degranulation, and the release of proteolytic enzymes along the basement membrane, ultimately leading to blister formation.<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref> Risk factors include mechanisms that disrupt the basement membrane, including ultraviolet light, radiation therapy, burns, vaccines, and surgical and accidental traumas.<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref> Certain medications have also been found to induce the disease.<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref> However in 85% patients, no precipitating factor is identified.<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref></p>
      <p>In the early, non-bullous phase, patients develop eczematous or urticarial lesions associated with severe pruritus, lasting weeks or months.<xref rid="b1-wjem-16-163" ref-type="bibr">1</xref>,<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref>&#x2013;<xref rid="b4-wjem-16-163" ref-type="bibr">4</xref> Patients eventually develop tense blisters that are localized or generalized, and may rupture.<xref rid="b1-wjem-16-163" ref-type="bibr">1</xref>,<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref> Only 10&#x2013;30% of patients have oral involvement.<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref> Proposed diagnostic criteria for bullous pemphigoid include tense blisters or erosions, histologic findings of subepidermal blisters with eosinophil infiltration, and direct immunofluorescence showing linear deposits of IgG and complement along the basement membrane.<xref rid="b1-wjem-16-163" ref-type="bibr">1</xref> Indirect immunofluorescence can also be performed to detect circulating serum auto-antibodies.<xref rid="b3-wjem-16-163" ref-type="bibr">3</xref></p>
      <p>First-line treatment consists of topical and systemic corticosteroids and azathioprine. Other treatments include mycophenolate mofetil, leflunomide, cyclophosphamide, methotrexate, dapsone, intravenous immunoglobulin, and plasmapharesis.<xref rid="b5-wjem-16-163" ref-type="bibr">5</xref> Bullous pemphigoid is typically chronic with spontaneous exacerbations and remissions.<xref rid="b5-wjem-16-163" ref-type="bibr">5</xref> It predisposes patients to secondary infections and sepsis, and mortality of bullous pemphigoid ranges 10&#x2013;40% in the first year following diagnosis.<xref rid="b6-wjem-16-163" ref-type="bibr">6</xref></p>
      <p>Our patient was fluid resuscitated and admitted for intravenous steroids. A skin biopsy confirmed the diagnosis. She was eventually discharged home on oral prednisone and mycophenolate mofetil.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn1-wjem-16-163">
        <p><italic>Supervising Section Editor:</italic> Sean O. Henderson, MD</p>
      </fn>
      <fn id="fn2-wjem-16-163">
        <p>Full text available through open access at <ext-link ext-link-type="uri" xlink:href="http://escholarship.org/uc/uciem_westjem">http://escholarship.org/uc/uciem_westjem</ext-link></p>
      </fn>
      <fn id="fn3-wjem-16-163">
        <p><italic>Conflicts of Interest</italic>: By the <italic>West</italic>JEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. The authors disclosed none.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-wjem-16-163">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kershenovich</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hodak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mimouni</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and classification of pemphigus and bullous pemphigoid</article-title>
          <source>Autoimmun Rev</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>477</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">24424192</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-wjem-16-163">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishie</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII</article-title>
          <source>J Dermatol Sci</source>
          <year>2014</year>
          <volume>73</volume>
          <fpage>179</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">24434029</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-wjem-16-163">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baum</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sakka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Artsi</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis and classification of autoimmune blistering diseases</article-title>
          <source>Autoimmun Rev</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>482</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">24434358</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-wjem-16-163">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schiavo</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Ruocco</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brancaccio</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies</article-title>
          <source>Clin Dermatol</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>391</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">23806156</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-wjem-16-163">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruocco</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caccavale</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bullous pemphigoid: associations and management guidelines: facts and controversies</article-title>
          <source>Clin Dermatol</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>400</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">23806157</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-wjem-16-163">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colbert</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Eastwood</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mortality rate of bullous pemphigoid in a US medical center</article-title>
          <source>J Invest Dermatol</source>
          <year>2004</year>
          <volume>122</volume>
          <fpage>1091</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">15140208</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-wjem-16-163" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Skin findings include tense bullae on erythematous bases, pruritic plaques on the hands, and urticaria.</p>
      </caption>
      <graphic xlink:href="wjem-16-163-g001"/>
    </fig>
    <fig id="f2-wjem-16-163" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Skin findings include tense bullae on erythematous bases and urticaria on the right inner thigh.</p>
      </caption>
      <graphic xlink:href="wjem-16-163-g002"/>
    </fig>
    <fig id="f3-wjem-16-163" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Skin findings include tense bullae on erythematous bases and urticaria on the left anterior thigh.</p>
      </caption>
      <graphic xlink:href="wjem-16-163-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
